Related references
Note: Only part of the references are listed.Long-term clinical outcomes of imiquimod 5% cream vs. diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials
H. Gollnick et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines
Carin A. T. C. Lunenburg et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2020)
The more the better? An appraisal of combination therapies for actinic keratosis
T. Steeb et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Core Outcome Set for Actinic Keratosis Clinical Trials
Kelly A. Reynolds et al.
JAMA DERMATOLOGY (2020)
The use of ingenol mebutate to treat actinic keratosis in standard clinical practice: a prospective phase IV multicenter observational cohort study
Eftychia Platsidaki et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2020)
A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis
T. Dirschka et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Local interventions for actinic keratosis in organ transplant recipients: a systematic review
M. V. Heppt et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Laser-assisted photodynamic therapy for actinic keratosis: A systematic review and meta-analysis
Theresa Steeb et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Eruptive epidermoid cysts after imiquimod treatment of recurrent basal cell carcinoma. A case report
Nora Woltsche et al.
HAUTARZT (2019)
Randomized Trial of Four Treatment Approaches for Actinic Keratosis
Maud H. E. Jansen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Photodynamic therapy for actinic keratosis of the forehead and scalp with the Aktilite CL 128: Is there a cut-off value for PpIX-weighted irradiance for effective treatment?
Claire Vicentini et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2019)
Multiple cutaneous squamous cell carcinoma after treatment with ingenol mebutate
C. Chabbert et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2019)
PDT with PPIX absorption peaks adjusted wavelengths: Safety and efficacy of a new irradiation procedure for actinic keratoses on the head
C. von Dobbeler et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2019)
Ingenol mebutate as topical treatment for actinic keratosis based on a prospective, non-interventional, multicentre study of real-life clinical practice in Germany: efficacy and quality of life
Thomas L. Diepgen et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2019)
Two cases of erosive pustular dermatosis of the scalp occurring after topical 3.75% imiquimod for actinic keratoses
Roberta Giuffrida et al.
DERMATOLOGIC THERAPY (2019)
Pharmacokinetics of ingenol mebutate gel under maximum use conditions in large treatment areas
Alicia D. Bucko et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2018)
Rapidly growing squamous cell carcinoma after ingenol mebutate treatment
M. Ehret et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2018)
Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0 center dot 015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp
E. Stockfleth et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
A multicentre, open, investigator-initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0•015% on the face and scalp, and 0•05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT)
Y. C. Kim et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
A real-world, community-based cohort study comparing the effectiveness of topical fluoruracil versus topical imiquimod for the treatment of actinic keratosis
Romain Neugebauer et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Pemphigus foliaceus induced by topical imiquimod treatment
Ken Shiraishi et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2018)
A dose-finding trial with a novel ingenol derivative (ingenol disoxate: LEO 43204) for field treatment of actinic keratosis on full face or 250cm2 on the chest
Marc Bourcier et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2017)
Treatment considerations in actinic keratosis
G. Goldenberg
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
The Systemic Response to Topical Aldara Treatment is Mediated Through Direct TLR7 Stimulation as Imiquimod Enters the Circulation
Louis Nerurkar et al.
SCIENTIFIC REPORTS (2017)
Occurrence of Acute Cerebellar Syndrome After Topical Application of Fluorouracil
Jo-David Fine et al.
JAMA DERMATOLOGY (2017)
Treatment of Multiple Actinic Keratosis and Field of Cancerization with Topical Piroxicam 0.8% and Sunscreen 50+ in Organ Transplant Recipients: A Series of 10 Cases
Virginia Garofalo et al.
CASE REPORTS IN DERMATOLOGY (2017)
Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial (vol 7, pg 81, 2017)
Eggert Stockfleth et al.
DERMATOLOGY AND THERAPY (2017)
A seamless phase I/II dose-finding trial assessing ingenol disoxate (LEO 43204) for field treatment of actinic keratosis on the scalp
J. Weiss et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial
Mario Puviani et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial
Eggert Stockfleth et al.
DERMATOLOGY AND THERAPY (2017)
A randomized, phase IIa exploratory trial to assess the safety and preliminary efficacy of LEO 43204 in patients with actinic keratosis
S. Sinnya et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study
Graziella Babino et al.
CURRENT MEDICAL RESEARCH AND OPINION (2016)
Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: Ready for prime time
Carin A. T. C. Lunenburg et al.
EUROPEAN JOURNAL OF CANCER (2016)
Transient memory impairment and transient global amnesia induced by photodynamic therapy
M. Reinholz et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Rapidly-growing squamous cell carcinoma shortly after treatment with ingenol mebutate for actinic keratoses: report of two cases
J. A. Moreno Romero et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Ingenol mebutate gel for actinic keratosis: The link between quality of life, treatment satisfaction, and clinical outcomes
Matthias Augustin et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe
J-P. Lacour et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp
C. Zane et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Comparative study of actinic keratosis treatment with 3% diclofenac sodium and 5% 5-fluorouracil
Majorie Mergen Segatto et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2013)
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis
T. Dirschka et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Severe photosensitivity reaction induced by topical diclofenac
Pramod B. Akat
INDIAN JOURNAL OF PHARMACOLOGY (2013)
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo
T. Dirschka et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Eczema Herpeticum Complicating Topical 5-Fluorouracil Therapy
Spencer W. Levesque et al.
DERMATITIS (2012)
Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: Rapid lesion necrosis followed by lesion-specific immune response
Robert H. Rosen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group
A. Pflugfelder et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Ingenol Mebutate Gel for Actinic Keratosis
Mark Lebwohl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results
E. Stockfleth et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Comparison of topical 3% diclofenac sodium gel and 5% imiquimod cream for the treatment of actinic keratoses
S. Akarsu et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2011)
Acute Renal Failure Caused by Imiquimod 5% Cream in a Renal Transplant Patient: Review of the Literature on Side Effects of Imiquimod
J. Santos-Juanes et al.
DERMATOLOGY (2011)
Long-term follow-up of metil aminolevulinate (MAL)-PDT in difficult-to-treat cutaneous Bowen's disease
Stefano Cavicchini et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2011)
Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity
Ursula Amstutz et al.
PHARMACOGENOMICS (2011)
Pharmacokinetics of imiquimod 3.75% cream applied daily for 3 weeks to actinic keratoses on the face and/or balding scalp
James Kulp et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2010)
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles
Neil Swanson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles
C. William Hanke et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses
Claas Ulrich et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2010)
Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial
K. Gebauer et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Actinic Keratoses Natural History and Risk of Malignant Transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial
Vincent D. Criscione et al.
CANCER (2009)
Pemphigus-like lesions induced by imiquimod
A. Bauza et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2009)
Contact pemphigus: a side-effect of imiquimod therapy
Ada Lo Schiavo et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2008)
Pityriasis rubra pilaris exacerbation with topical use of imiquimod
F. Clarissa Yang et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2008)
Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients
C. Ulrich et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up
N. Krawtchenko et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Erosive cheilitis after facial application of imiquimod 5% cream
A. Campanelli et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2007)
Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head
Joseph Jorizzo et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy
C. M. Perrett et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Squamous cell carcinoma on the scalp following treatment with 5% imiquimod cream
S. Singh et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2007)
Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod
P. A. Fanti et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2006)
A clinical comparison and long-term follow-up of topical 5-fluorouracil versus laser resurfacing in the treatment of widespread actinic keratoses
Judith U. Ostertag et al.
LASERS IN SURGERY AND MEDICINE (2006)
Invasive squamous cell carcinoma after treatment of carcinoma in situ with 5% imiquimod cream
MSY Goh
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2006)
A case of severe eczema following use of imiquimod 5% cream
C. L. Taylor et al.
SEXUALLY TRANSMITTED INFECTIONS (2006)
Imiquimod for actinic keratosis: Systematic review and meta-analysis
Gina Hadley et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Topical imiquimod: mechanism of action and clinical applications
D Vidal
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development
Y. M. Sung et al.
ONCOGENE (2006)
Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients - Randomized, double-blind, placebo-controlled trial
VL Brown et al.
ARCHIVES OF DERMATOLOGY (2005)
Antitumor activity of 3-ingenyl angelate: Plasma membrane and mitochondrial disruption and necrotic cell death
SM Ogbourne et al.
CANCER RESEARCH (2004)
Treatment of Bowen's disease with imiquimod 5% cream in transplant recipients
BM Prinz et al.
TRANSPLANTATION (2004)
Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology
RM Szeimies et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases
T Nijsten et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis
K Loven et al.
CLINICAL THERAPEUTICS (2002)
Topical treatment of actinic keratoses with 3.0% diclofcnac in 2.5% hyaluronan gel
JK Rivers et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
A pharmacokinetic evaluation of 0.5% and 5% fluorouracil topical cream in patients with actinic keratosis
S Levy et al.
CLINICAL THERAPEUTICS (2001)
Share Paper
